Structural comparison of protiated, H/D-exchanged and deuterated human carbonic anhydrase IX.

Q4 Engineering
K Koruza, B Lafumat, M Nyblom, B P Mahon, W Knecht, R McKenna, S Z Fisher
{"title":"Structural comparison of protiated, H/D-exchanged and deuterated human carbonic anhydrase IX.","authors":"K Koruza, B Lafumat, M Nyblom, B P Mahon, W Knecht, R McKenna, S Z Fisher","doi":"10.1107/S2059798319010027","DOIUrl":null,"url":null,"abstract":"<p><p>Human carbonic anhydrase IX (CA IX) expression is upregulated in hypoxic solid tumours, promoting cell survival and metastasis. This observation has made CA IX a target for the development of CA isoform-selective inhibitors. To enable structural studies of CA IX-inhibitor complexes using X-ray and neutron crystallography, a CA IX surface variant (CA IX<sub>SV</sub>; the catalytic domain with six surface amino-acid substitutions) has been developed that can be routinely crystallized. Here, the preparation of protiated (H/H), H/D-exchanged (H/D) and deuterated (D/D) CA IX<sub>SV</sub> for crystallographic studies and their structural comparison are described. Four CA IX<sub>SV</sub> X-ray crystal structures are compared: two H/H crystal forms, an H/D crystal form and a D/D crystal form. The overall active-site organization in each version is essentially the same, with only minor positional changes in active-site solvent, which may be owing to deuteration and/or resolution differences. Analysis of the crystal contacts and packing reveals different arrangements of CA IX<sub>SV</sub> compared with previous reports. To our knowledge, this is the first report comparing three different deuterium-labelled crystal structures of the same protein, marking an important step in validating the active-site structure of CA IX<sub>SV</sub> for neutron protein crystallography.</p>","PeriodicalId":35437,"journal":{"name":"Journal of the Illuminating Engineering Institute of Japan (Shomei Gakkai Shi)","volume":"86 1","pages":"895-903"},"PeriodicalIF":0.0000,"publicationDate":"2019-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6778848/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Illuminating Engineering Institute of Japan (Shomei Gakkai Shi)","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1107/S2059798319010027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/8/22 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0

Abstract

Human carbonic anhydrase IX (CA IX) expression is upregulated in hypoxic solid tumours, promoting cell survival and metastasis. This observation has made CA IX a target for the development of CA isoform-selective inhibitors. To enable structural studies of CA IX-inhibitor complexes using X-ray and neutron crystallography, a CA IX surface variant (CA IXSV; the catalytic domain with six surface amino-acid substitutions) has been developed that can be routinely crystallized. Here, the preparation of protiated (H/H), H/D-exchanged (H/D) and deuterated (D/D) CA IXSV for crystallographic studies and their structural comparison are described. Four CA IXSV X-ray crystal structures are compared: two H/H crystal forms, an H/D crystal form and a D/D crystal form. The overall active-site organization in each version is essentially the same, with only minor positional changes in active-site solvent, which may be owing to deuteration and/or resolution differences. Analysis of the crystal contacts and packing reveals different arrangements of CA IXSV compared with previous reports. To our knowledge, this is the first report comparing three different deuterium-labelled crystal structures of the same protein, marking an important step in validating the active-site structure of CA IXSV for neutron protein crystallography.

原态、H/D 交换和氚化人碳酸酐酶 IX 的结构比较。
人类碳酸酐酶 IX(CA IX)在缺氧性实体瘤中表达上调,促进细胞存活和转移。这一观察结果使 CA IX 成为开发 CA 同工酶选择性抑制剂的目标。为了利用 X 射线和中子晶体学对 CA IX-抑制剂复合物进行结构研究,我们开发了一种可常规结晶的 CA IX 表面变体(CA IXSV;催化结构域有六个表面氨基酸取代)。本文介绍了用于晶体学研究的原态(H/H)、H/D 交换(H/D)和氚化(D/D)CA IXSV 的制备及其结构比较。比较了四种 CA IXSV X 射线晶体结构:两种 H/H 晶体、一种 H/D 晶体和一种 D/D 晶体。每种晶体的整体活性位点组织结构基本相同,只有活性位点溶剂的位置发生了细微变化,这可能是由于氘化和/或分辨率的差异造成的。对晶体接触和堆积的分析表明,CA IXSV 的排列与以前的报告有所不同。据我们所知,这是第一份比较同一蛋白质的三种不同氘标记晶体结构的报告,标志着为中子蛋白质晶体学验证 CA IXSV 活性位点结构迈出了重要一步。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of the Illuminating Engineering Institute of Japan (Shomei Gakkai Shi)
Journal of the Illuminating Engineering Institute of Japan (Shomei Gakkai Shi) Engineering-Electrical and Electronic Engineering
CiteScore
0.10
自引率
0.00%
发文量
6
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信